Lab result explainedVitamins and mineralsLast updated November 8, 2026

Phosphorus blood test: what high and low phosphate levels mean

Phosphorus (serum phosphate) (Phos) · Added to a metabolic panel; standard in renal, bone and nutrition panels · reported in mg/dL (some labs report mmol/L — multiply mg/dL by 0.323)

Phosphorus is the second most abundant mineral in your body after calcium, and a phosphorus blood test (also called serum phosphate) measures the small fraction, about 1 percent, that circulates in the blood rather than sitting in bone or inside cells. Normal for adults is 2.5 to 4.5 mg/dL on most US reports; children run higher, 4.0 to 7.0 mg/dL, because growing bone needs more. Phosphorus is not part of a routine basic metabolic panel, so most people see it when a clinician is checking kidneys, bones, parathyroid glands, vitamin D or nutrition.

The kidneys hold the level steady by adjusting how much phosphate they pass into urine, under instruction from parathyroid hormone (PTH), a bone hormone called FGF23 and active vitamin D. When the kidneys fail, phosphorus accumulates: high phosphorus (hyperphosphatemia) is the signature mineral problem of advanced chronic kidney disease and is tied to blood vessel calcification and higher mortality in that group. In people with normal kidneys, a high phosphorus is more often a sample problem, an underactive parathyroid gland or a phosphate-containing laxative.

Low phosphorus (hypophosphatemia) is the result that catches people out, because it causes no symptoms until it is severe and then can be dangerous. The usual causes are shifting phosphate into cells, as happens when a starved or malnourished person is fed again (refeeding syndrome) or when diabetic ketoacidosis is treated with insulin, losing it through the kidneys in hyperparathyroidism or with certain intravenous iron infusions, and heavy alcohol use. Below 1.0 mg/dL the muscles, heart, nerves and red cells begin to fail and treatment is urgent.

Phos at a glance

What it is: the inorganic phosphate in your blood, about 1 percent of total body phosphorus; the rest is in bone (85 percent) and inside cells. Needed for bone, energy (ATP), cell membranes and DNA.
Normal: 2.5–4.5 mg/dL for adults (some labs 2.8–4.5 or 3.0–4.5); children 4.0–7.0 mg/dL. Some labs report mmol/L: multiply mg/dL by 0.323.
High (hyperphosphatemia): above 4.5 mg/dL. Most often chronic kidney disease (eGFR under 30), an underactive parathyroid, phosphate laxatives or a hemolysed sample; above 6–7 mg/dL can drop calcium and cause tingling and cramps.
Low (hypophosphatemia): below 2.5 mg/dL. Mild 2.0–2.5 is usually silent; moderate 1.0–2.0 can cause weakness; below 1.0 mg/dL is a medical emergency with risk of muscle breakdown, breathing failure and arrhythmia.
Commonest causes of low phosphorus: refeeding after starvation, alcohol use disorder, insulin treatment of diabetic ketoacidosis, hyperparathyroidism, vitamin D deficiency, some IV iron infusions, phosphate-binding antacids and chronic diarrhea.
Next step: repeat fasting in the morning, check calcium, PTH, vitamin D, creatinine and eGFR, and magnesium; the cause determines treatment, from diet changes to phosphate binders in kidney disease or supplements for deficiency.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What Phos measures

The test measures inorganic phosphate ions in serum or plasma, mostly as HPO4 and H2PO4, by a colorimetric reaction with ammonium molybdate. It reports phosphorus by weight (mg/dL) even though what is measured is phosphate; the terms are used interchangeably on reports. The organic phosphorus bound up in phospholipids, ATP and DNA is not included. Because only 1 percent of body phosphorus is in blood, the serum level is a poor guide to total stores: a person can be profoundly depleted with a normal level until something shifts the balance, or have a normal body content with a low level because phosphate has moved into cells.

Three hormones set the level. Parathyroid hormone increases phosphate loss in urine, so an overactive parathyroid lowers phosphorus and an underactive one raises it. FGF23, released by bone when phosphate intake is high, does the same and also switches off vitamin D activation. Active vitamin D (calcitriol) increases absorption of both calcium and phosphorus from the gut. The kidneys filter about 7 g of phosphate a day and reabsorb 80 to 90 percent of it; as kidney function falls below an eGFR of about 30 to 40, this capacity is overwhelmed, FGF23 and PTH rise steeply to compensate, and the level eventually climbs.

Phosphorus has a marked daily rhythm, lowest in the late morning and up to 1 mg/dL higher in the evening, and a carbohydrate meal or a dose of insulin drives it into cells within an hour, so a fasting morning sample is standard. Hemolysis of the sample, delayed separation of the serum and very high platelet or white cell counts release phosphate and falsely raise the result, as do some paraproteins in myeloma and high-dose liposomal amphotericin; a surprising high value with normal kidneys is often a repeat-the-sample problem. Vigorous exercise before the draw raises it transiently, and hyperventilation lowers it.

Normal range for Phos

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

Group	Typical range (mg/dL (some labs report mmol/L — multiply mg/dL by 0.323))	Notes
Adults, normal	2.5–4.5 mg/dL (0.81–1.45 mmol/L)	Some labs use 2.8–4.5 or 3.0–4.5 mg/dL. Use the interval on your report; a fasting morning sample is the reference condition.
Children	About 4.0–7.0 mg/dL in infants and young children; 3.0–6.0 mg/dL in older children and adolescents	Higher levels support bone growth; growth hormone and lower FGF23 keep renal reabsorption high. Adult values are reached in the late teens.
Mild hypophosphatemia	2.0–2.5 mg/dL	Usually without symptoms; often a shift into cells after a meal, hyperventilation or a glucose infusion. Repeat fasting before acting.
Moderate hypophosphatemia	1.0–2.0 mg/dL	Muscle weakness, bone pain and fatigue possible, especially if prolonged. Investigated and usually treated with oral phosphate or diet.
Severe hypophosphatemia	Below 1.0 mg/dL	Medical emergency: risk of muscle breakdown, respiratory failure, heart failure, arrhythmia, seizures and red cell breakdown. Treated intravenously in hospital.
Mild to moderate hyperphosphatemia	4.5–6.0 mg/dL	Common in chronic kidney disease stages 4 to 5; also hypoparathyroidism, phosphate laxatives, acidosis or a hemolysed sample. KDIGO advises lowering toward the normal range in kidney disease.
Severe hyperphosphatemia	Above 6.0–7.0 mg/dL	Calcium often falls as calcium phosphate precipitates; tingling, cramps and tetany appear. Values above 8–10 mg/dL occur in tumor lysis syndrome, rhabdomyolysis and after sodium phosphate bowel preparations in people with kidney impairment.
Dietary reference	RDA 700 mg a day for adults; 1,250 mg for ages 9 to 18; upper limit 4,000 mg (3,000 mg over age 70)	Average US intake is 1,200 to 1,500 mg a day, well above the RDA, largely from dairy, meat, grains and phosphate additives in processed food.

High phosphorus (hyperphosphatemia)

A phosphorus above 4.5 mg/dL means the kidneys are not excreting as much phosphate as is entering the blood, or phosphate is being released rapidly from cells or bone. By far the most common cause of a genuinely high result is chronic kidney disease. Once the eGFR falls below about 30 mL/min, the kidneys can no longer clear the daily dietary load despite high levels of FGF23 and parathyroid hormone, and phosphorus climbs. In kidney disease this matters: high phosphorus drives secondary hyperparathyroidism and bone disease, and it is associated with calcification of arteries and heart valves and with higher cardiovascular mortality, with risk rising at levels above about 5.5 mg/dL in dialysis patients. Guidelines advise bringing it toward normal with diet, phosphate binders and adequate dialysis.

When the kidneys are working normally, a high phosphorus has a different list of explanations. The first is the sample itself: hemolysis, a delay in separating serum, or very high platelet or white cell counts release phosphate from cells after the blood is drawn, and a repeat fasting sample handled promptly is often normal. The second is an underactive parathyroid gland (hypoparathyroidism), usually after thyroid or neck surgery, which lets the kidneys hold on to phosphate; here calcium is low at the same time. Phosphate-containing laxatives and enemas (sodium phosphate bowel preparations), vitamin D toxicity, untreated diabetic ketoacidosis, acromegaly and bisphosphonate therapy are other causes, and phosphorus is physiologically higher in children and adolescents.

Very high levels, above 6 to 7 mg/dL, bind calcium and can drop it enough to cause tingling, cramps and tetany, and when the calcium-phosphorus product (the two values multiplied) exceeds about 55 to 70 mg2/dL2, calcium phosphate can deposit in soft tissues, skin and blood vessels. Acute rises to 8 to 10 mg/dL or more come from massive cell breakdown, as in tumor lysis syndrome during chemotherapy, rhabdomyolysis or severe hemolysis, and from sodium phosphate bowel preparations in people with kidney impairment, where acute phosphate nephropathy can cause permanent kidney damage.

Common causes

Chronic kidney disease
Excretion fails once the eGFR drops below about 30 mL/min; phosphorus rises progressively through stages 4 and 5 and is highest on dialysis. It is the dominant cause of a persistently high level in adults and is managed with diet, binders and dialysis adequacy.
Acute kidney injury
A sudden fall in filtration from dehydration, sepsis, drugs or obstruction raises phosphorus within days, often with high potassium and acidosis; it reverses as kidney function recovers.
Hemolysed or delayed sample, high platelets or white cells (pseudohyperphosphatemia)
Phosphate leaks out of red cells, platelets and white cells after the draw; a traumatic venepuncture, a sample left standing, a platelet count above 1,000,000 or a leukemia with a very high white count can produce a falsely high result. Paraproteins in myeloma and liposomal amphotericin B interfere with the assay directly.
Hypoparathyroidism and pseudohypoparathyroidism
Without parathyroid hormone (most often after thyroid or parathyroid surgery, or from autoimmune or genetic causes) the kidneys reabsorb phosphate avidly and calcium falls; the combination of high phosphorus and low calcium with normal kidneys is the clue. In pseudohypoparathyroidism the hormone is present but the kidney does not respond.
Sodium phosphate laxatives, enemas and bowel preparations
Oral sodium phosphate bowel preparations deliver 10 to 12 g of phosphate and can push levels above 8 mg/dL, especially in older adults, those with kidney impairment or on ACE inhibitors or diuretics; the FDA warns of acute phosphate nephropathy. Fleet-type enemas have caused severe hyperphosphatemia in children and older adults.
Tumor lysis syndrome, rhabdomyolysis and massive hemolysis
Rapid breakdown of large numbers of cells releases their phosphate (and potassium and uric acid) faster than the kidneys can clear it, often causing acute kidney injury that compounds the rise. Phosphorus above 8 to 10 mg/dL with low calcium is typical.
Vitamin D toxicity
Excess vitamin D (usually from supplements above 10,000 IU a day for months, with 25-hydroxyvitamin D above 150 ng/mL) increases gut absorption of both calcium and phosphorus; high calcium is the more prominent finding.
Diabetic ketoacidosis and lactic acidosis before treatment
Acidosis and insulin deficiency shift phosphate out of cells, so the level is often high at presentation despite a large total-body deficit; it then falls, sometimes sharply, once insulin is given.
Acromegaly and growth in childhood
Growth hormone increases renal phosphate reabsorption, which is why children run higher levels and why acromegaly raises phosphorus in adults.
Bisphosphonates and some other drugs
Intravenous bisphosphonates, excess phosphate in parenteral nutrition, fosfomycin and vitamin D analogues can raise phosphorus modestly; the effect is clinically significant mainly when kidney function is reduced.

Symptoms that can go with it

Usually none; high phosphorus is found on testing, particularly in kidney disease
Tingling around the mouth and in the fingers, muscle cramps or spasms, from the fall in calcium that accompanies a high phosphorus
Itching, which is common in dialysis patients with high phosphorus
Bone and joint pain, from secondary hyperparathyroidism and renal bone disease
Hard lumps under the skin or around joints (calcinosis) and, in advanced kidney disease, painful skin ulcers from calciphylaxis
Red eyes from conjunctival calcium deposits in long-standing kidney disease
In acute severe cases: confusion, seizures, irregular heartbeat and low blood pressure as calcium plummets

Low phosphorus (hypophosphatemia)

A phosphorus below 2.5 mg/dL can mean one of three things: phosphate has moved from the blood into cells, the kidneys are losing it, or you are not absorbing enough. Shifts into cells are the most common cause of a mildly low result in hospital and the most dangerous cause of a severely low one. Any surge of insulin, from a carbohydrate meal or infusion, from insulin treatment of diabetic ketoacidosis, or from refeeding after days of starvation, drives phosphate into cells to make ATP. In a malnourished person whose stores are already empty, this refeeding shift can drop phosphorus below 1.0 mg/dL within one to three days of starting to eat, which is why hospitals monitor it closely in anorexia nervosa, alcohol use disorder and after prolonged fasting. Hyperventilation (respiratory alkalosis) shifts phosphate into cells too, and is a common cause of a transient low value in anxious or septic patients.

Kidney losses are the second group. Primary hyperparathyroidism, usually from a benign parathyroid adenoma, raises PTH, which increases urinary phosphate loss; the combination of a low phosphorus and a high calcium is the classic clue, and hyperparathyroidism is the commonest cause in an otherwise well outpatient. Vitamin D deficiency produces a milder version through secondary hyperparathyroidism. Intravenous ferric carboxymaltose, a widely used iron infusion, raises FGF23 and causes hypophosphatemia in about half to three-quarters of recipients, occasionally severe and prolonged; other iron formulations do so far less often. Inherited phosphate-wasting disorders (X-linked hypophosphatemia), tumor-induced osteomalacia, Fanconi syndrome from drugs such as tenofovir or ifosfamide, and diuretics also increase losses.

Poor intake or absorption completes the list: alcohol use disorder (which combines poor diet, kidney losses, magnesium deficiency and shifts during withdrawal), chronic diarrhea and malabsorption, aluminum- or magnesium-containing antacids and other phosphate binders taken long term, and eating disorders. Prolonged moderate deficiency weakens bone (osteomalacia in adults, rickets in children) and muscle; severe deficiency, below 1.0 mg/dL, starves cells of ATP and 2,3-DPG, causing muscle breakdown, respiratory muscle failure, heart failure, arrhythmias, confusion, seizures and hemolysis. The level is read with calcium, PTH, vitamin D, magnesium, kidney function and, when the cause is unclear, a measurement of how much phosphate is in the urine.

Common causes

Refeeding syndrome
Reintroducing food, tube feeds or intravenous nutrition after 5 or more days of little intake, or in anyone malnourished (anorexia nervosa, alcohol use disorder, cancer, after bariatric surgery), triggers insulin release that drives phosphate into cells; levels can fall below 1.0 mg/dL within 72 hours. Guidelines call for checking phosphorus before and daily during the first week of refeeding.
Alcohol use disorder
Poor diet, vomiting and diarrhea, kidney losses from alcohol and low magnesium, and shifts during withdrawal and refeeding combine to make this the commonest cause of severe hypophosphatemia in hospital; up to half of people admitted with alcohol withdrawal have a low level.
Treatment of diabetic ketoacidosis and hyperglycemia
Osmotic diuresis depletes total-body phosphate while acidosis keeps the blood level up; once insulin and fluids are started, phosphate pours into cells and the level can drop to 1.0 mg/dL or lower within 12 to 24 hours.
Primary hyperparathyroidism
Excess PTH makes the kidneys dump phosphate while raising calcium; the pairing of a low or low-normal phosphorus with a high calcium is the typical outpatient finding and points to a parathyroid adenoma.
Vitamin D deficiency and osteomalacia
Low vitamin D reduces gut absorption of phosphate and raises PTH, which increases urinary loss; the result is a low-normal or low phosphorus with a low calcium and raised alkaline phosphatase, and in severe cases bone pain and fractures.
Intravenous iron (ferric carboxymaltose)
Ferric carboxymaltose raises FGF23 and causes hypophosphatemia in 50 to 75 percent of recipients in trials, against about 8 percent with iron derisomaltose and low rates with iron sucrose or ferumoxytol; it can persist for weeks, recur with repeat doses and occasionally cause osteomalacia.
Antacids and phosphate binders
Aluminum hydroxide, magnesium hydroxide, calcium carbonate, sevelamer and lanthanum bind dietary phosphate in the gut; long-term heavy use of over-the-counter antacids is a classic cause of deficiency in people with normal kidneys.
Chronic diarrhea, malabsorption and bariatric surgery
Celiac disease, Crohn's disease, short bowel, chronic laxative use and gastric bypass reduce absorption, often alongside low vitamin D, calcium and magnesium.
Respiratory alkalosis
Hyperventilation from anxiety, pain, sepsis, salicylate poisoning or liver failure raises intracellular pH and pulls phosphate into cells; levels can fall below 1.5 mg/dL transiently and recover when breathing settles.
Renal phosphate wasting: Fanconi syndrome, X-linked hypophosphatemia, tumor-induced osteomalacia, diuretics
Tenofovir, ifosfamide, cisplatin and heavy-metal toxicity damage the proximal tubule (Fanconi syndrome); inherited X-linked hypophosphatemia and rare FGF23-secreting tumors cause life-long or acquired wasting with bone pain and fractures; loop and thiazide diuretics add a modest loss.

Symptoms that can go with it

None when mildly low (2.0 to 2.5 mg/dL)
Muscle weakness, particularly in the thighs and shoulders, difficulty climbing stairs and general fatigue
Bone pain, tenderness and fractures from osteomalacia when the deficiency is long-standing
Loss of appetite, nausea and confusion or irritability
Numbness and tingling, tremor and, in severe cases, seizures or coma
Breathlessness from weak breathing muscles, which can progress to respiratory failure below 1.0 mg/dL
Dark urine from muscle breakdown (rhabdomyolysis) or red cell breakdown (hemolysis) in severe deficiency
Palpitations or arrhythmia and, rarely, acute heart failure in the severe range

Read it alongside

Calcium — the two move in opposite directions in parathyroid disease (low phosphorus with high calcium in hyperparathyroidism; high phosphorus with low calcium in hypoparathyroidism) and their product predicts soft-tissue calcification in kidney disease.
Creatinine and eGFR — decide whether a high phosphorus is explained by kidney disease; levels rise once eGFR falls below about 30 mL/min.
Parathyroid hormone (PTH) — high PTH with low phosphorus points to primary hyperparathyroidism; low PTH with high phosphorus to hypoparathyroidism; high PTH with high phosphorus to kidney disease.
Vitamin D (25-hydroxyvitamin D) — deficiency lowers phosphorus modestly and toxicity raises it; checked whenever bone symptoms or an abnormal calcium accompany the result.
Alkaline phosphatase — raised in osteomalacia, rickets and renal bone disease, where phosphorus is often abnormal.
Magnesium — low magnesium commonly accompanies low phosphorus in alcohol use disorder, refeeding and malabsorption, and must be corrected alongside it.
Potassium and glucose — fall together with phosphorus during refeeding and insulin treatment of ketoacidosis; monitored daily in those settings.
Urine phosphate (fractional excretion or tubular reabsorption) — distinguishes kidney wasting (FePO4 above 5 percent or TmP/GFR low) from intake or shift problems when the cause of a low level is unclear.

What usually happens next

An unexpected abnormal result is repeated on a fasting morning sample that is separated promptly, since meals, time of day, exercise and hemolysis all move phosphorus by 0.5 to 1 mg/dL.
Expect calcium (corrected for albumin), creatinine and eGFR, PTH, 25-hydroxyvitamin D and magnesium to be checked alongside; this set explains most results, and a urine phosphate is added if a low level remains unexplained.
In chronic kidney disease, a rising phosphorus prompts dietary counselling (phosphate additives first, then portion control of high-phosphorus foods), a review of dialysis adequacy if applicable, and phosphate binders taken with meals if diet is not enough; KDIGO guidelines aim toward the normal range rather than a fixed target.
For a low phosphorus, treatment follows the cause: oral phosphate (dairy, or sodium or potassium phosphate preparations) for mild to moderate deficiency, intravenous phosphate in hospital below 1.0 mg/dL or with symptoms, vitamin D repletion when deficient, and careful, monitored refeeding in malnutrition.
If you have had a ferric carboxymaltose iron infusion and feel weak or have bone pain, ask for a phosphorus level; recurrent infusions may be switched to another formulation.
Low phosphorus with a high calcium is usually followed by a repeat PTH and a referral for primary hyperparathyroidism, which surgery usually corrects.

Diet, lifestyle and natural levers with evidence

What can move Phos once the cause is known. Nothing here replaces finding the cause.

Avoiding phosphate additives in processed food (for high phosphorus)

Strong evidence

Inorganic phosphate additives in colas, processed meats, cheese products, baked goods and fast food are 90 to 100 percent absorbed, compared with 40 to 60 percent of the phosphorus in meat and dairy and 20 to 50 percent of that in beans and grains, and they add 500 to 1,000 mg a day to many diets without appearing on nutrition labels. In a randomised trial of 279 dialysis patients, teaching people to read ingredient lists for 'phos' additives lowered serum phosphorus by 0.6 mg/dL more than usual care over three months, an effect comparable to adding a binder. A 12 oz cola contains 40 to 70 mg of phosphoric acid phosphorus and is the easiest single swap.

Shifting toward plant protein sources (for high phosphorus in kidney disease)

Moderate evidence

Phosphorus in plant foods is bound as phytate, which humans absorb poorly, so beans, lentils, nuts and whole grains deliver far less absorbable phosphorus than the label suggests. In a crossover trial in people with chronic kidney disease, one week of a vegetarian diet matched for protein and phosphorus lowered serum phosphorus and FGF23 compared with a meat-based week. Observational studies in dialysis patients link higher plant-protein intake to lower phosphorus and mortality. Protein intake itself should not be cut below what your clinician advises, since malnutrition is a greater risk than phosphorus in advanced kidney disease.

Potassium is high in many plant foods; people with advanced kidney disease need individual dietitian guidance to balance the two.

Boiling meat and vegetables before eating (for high phosphorus)

Preliminary evidence

Phosphorus is water-soluble, and boiling meat, fish or vegetables in plenty of water and discarding it removes 30 to 50 percent of the phosphorus while preserving most of the protein; cutting food into small pieces before boiling increases the loss. Small studies in dialysis patients using boiled rather than grilled or roasted meat show meaningful reductions in dietary phosphorus load, though effects on serum levels in trials are modest and it is used as an adjunct to additive avoidance and binders.

Nicotinamide (niacinamide) in dialysis patients

Moderate evidence

Nicotinamide blocks the sodium-phosphate transporter in the gut. In a randomised placebo-controlled trial in hemodialysis patients, 500 to 1,500 mg a day lowered serum phosphorus from 6.3 to 5.5 mg/dL over 8 weeks while it rose on placebo, and meta-analyses of around a dozen trials report an average reduction of about 0.7 mg/dL. It is used as an add-on to binders in some centres rather than a first-line treatment.

Only under medical supervision in kidney disease: nicotinamide can cause a fall in platelets, flushing, nausea, diarrhea and, at high doses, liver enzyme rises. Not appropriate for self-treatment and not useful for people with normal kidney function.

Dairy, meat, fish, nuts and legumes (for low phosphorus)

Strong evidence

Food is the first-line treatment for mild to moderate hypophosphatemia without severe symptoms. Milk supplies about 250 mg of phosphorus per cup (and the calcium and vitamin D that go with it), yogurt 250 to 350 mg per cup, salmon or chicken 200 to 250 mg per 3 oz, lentils 180 mg per cup and almonds 140 mg per oz. Two to three servings of dairy a day plus protein at each meal delivers 1,000 to 1,500 mg, which restores mild deficiency within a week or two once the underlying cause (alcohol, antacids, diarrhea) is addressed. Hospital guidelines use skimmed milk, a litre of which contains about 1 g of phosphorus, as a first step for mild cases.

Correcting vitamin D deficiency

Strong evidence

Vitamin D increases gut absorption of phosphorus and, by suppressing PTH, reduces urinary loss, so repleting a deficiency (25-hydroxyvitamin D below 20 ng/mL) normalises a low or low-normal phosphorus within weeks and heals osteomalacia over months. In trials of nutritional osteomalacia, 50,000 IU weekly for 8 weeks or equivalent daily dosing raised serum phosphorus by 0.5 to 1 mg/dL and lowered alkaline phosphatase. Vitamin D also raises phosphorus modestly in people without deficiency, which is why it is used cautiously in advanced kidney disease.

In chronic kidney disease vitamin D can raise phosphorus and calcium; doses are set by the kidney team. Avoid long-term intake above 4,000 IU a day without monitoring.

When to see a clinician promptly

A phosphorus below 1.0 mg/dL, or below 1.5 mg/dL with muscle weakness, breathlessness, confusion, dark urine or palpitations: same-day hospital assessment, since intravenous replacement and monitoring are needed.
A phosphorus above 6.0 mg/dL, or any high level with tingling around the mouth, muscle cramps or spasms, seizures or an irregular heartbeat, which suggest a dangerous fall in calcium.
Weakness, confusion or a falling phosphorus in the first days after starting to eat again after a period of starvation, in anorexia nervosa or heavy drinking, or after starting tube or intravenous feeding: refeeding syndrome can be fatal and is treated by slowing feeding and replacing electrolytes.
A low phosphorus with a high calcium, or with bone pain, fractures or kidney stones, which points to hyperparathyroidism.
A high phosphorus with a creatinine or eGFR that has worsened, particularly after a sodium phosphate bowel preparation, which can indicate acute phosphate nephropathy.
Persistently abnormal phosphorus in a child, since both rickets (low) and some kidney conditions (high) need early treatment to protect growth.

Frequently asked questions

What is a normal phosphorus level in blood?

For adults, 2.5 to 4.5 mg/dL on most US reports, with some labs using 2.8 to 4.5 or 3.0 to 4.5. Children run higher, about 4.0 to 7.0 mg/dL in young children and 3.0 to 6.0 in adolescents, because growing bone needs more. If your lab reports mmol/L, multiply mg/dL by 0.323: 2.5 to 4.5 mg/dL equals 0.81 to 1.45 mmol/L. A fasting morning sample is the standard, as food and time of day shift the level by up to 1 mg/dL.

What causes high phosphorus levels?

Chronic kidney disease is the main cause of a persistently high phosphorus, because the kidneys can no longer excrete the daily load once eGFR is below about 30. In people with normal kidneys, the usual explanations are a hemolysed or delayed blood sample, an underactive parathyroid gland (usually after neck surgery), sodium phosphate laxatives or bowel preparations, vitamin D toxicity, untreated diabetic ketoacidosis, and rapid cell breakdown from tumor lysis or rhabdomyolysis. Children and teenagers normally run higher levels than adults.

What causes low phosphate levels?

Phosphate moving into cells (refeeding after starvation, insulin treatment of diabetic ketoacidosis, hyperventilation), losing it through the kidneys (primary hyperparathyroidism, vitamin D deficiency, ferric carboxymaltose iron infusions, diuretics, Fanconi syndrome from drugs such as tenofovir, inherited phosphate wasting) or not absorbing enough (alcohol use disorder, chronic diarrhea, malabsorption, long-term antacid or phosphate binder use, eating disorders). In a well outpatient, hyperparathyroidism and vitamin D deficiency are the commonest; in hospital, refeeding and alcohol are.

What are the symptoms of low phosphorus?

Mild hypophosphatemia (2.0 to 2.5 mg/dL) causes none. Between 1.0 and 2.0 mg/dL people may notice muscle weakness, fatigue, bone pain, loss of appetite and irritability or confusion. Below 1.0 mg/dL, cells run short of energy: breathing muscles weaken, muscle fibres break down (dark urine), red cells burst, the heart can fail or develop arrhythmias, and seizures or coma can occur. Severe hypophosphatemia is a medical emergency treated with intravenous phosphate.

Why is phosphorus high in kidney disease and why does it matter?

Healthy kidneys filter about 7 g of phosphate a day and adjust how much they reabsorb to keep the blood level steady. As kidney function falls, the hormones FGF23 and PTH rise to force out more phosphate, which works until eGFR drops below about 30 mL/min; after that phosphorus accumulates. High phosphorus in kidney disease feeds secondary hyperparathyroidism and bone disease, encourages calcium phosphate deposits in arteries and heart valves, and is associated with higher cardiovascular death rates, with risk rising above about 5.5 mg/dL in dialysis patients. Diet, binders and dialysis are used to bring it toward normal.

What foods are high in phosphorus?

Dairy (milk, yogurt, cheese), meat, poultry, fish, eggs, nuts, seeds, beans, lentils and whole grains are the main natural sources; a cup of milk has about 250 mg and 3 oz of salmon about 250 mg. The most absorbable phosphorus, and the easiest to cut, comes from additives in colas and dark sodas, processed meats, processed cheese, fast food and many baked goods, which are absorbed almost completely. Phosphorus in plant foods is bound as phytate and only 20 to 50 percent absorbed, so beans and nuts contribute less than their labels suggest.

Does phosphate have to be checked fasting?

Ideally, yes. Phosphorus has a daily rhythm, lowest in the late morning and up to 1 mg/dL higher in the evening, and a carbohydrate-rich meal or glucose drink moves phosphate into cells and lowers the blood level for an hour or two. A fasting morning sample is the standard reference condition, and an unexpected low or high result is usually repeated fasting before anything is concluded. Avoid vigorous exercise beforehand, and if the first result was high with normal kidney function, ask whether the sample may have been hemolysed.

Can iron infusions cause low phosphate?

Yes, particularly ferric carboxymaltose (Injectafer). It raises the hormone FGF23, which makes the kidneys waste phosphate, and in randomised trials about half to three-quarters of recipients developed hypophosphatemia, compared with roughly 8 percent after iron derisomaltose and low rates with iron sucrose or ferumoxytol. The drop usually peaks at two weeks and resolves within one to three months, but it can be severe, recur with repeated infusions and occasionally cause bone softening. If you have had this infusion and feel weak or have bone pain, ask for a phosphorus level.

References

Phosphate in blood. MedlinePlus, US National Library of Medicine (2023)View source
Phosphorus: fact sheet for health professionals. National Institutes of Health, Office of Dietary Supplements (2023)View source
Hyperphosphatemia. Merck Manual Professional Version (2023)
Hypophosphatemia. Merck Manual Professional Version (2023)
Kidney Disease: Improving Global Outcomes CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney International Supplements (2017)
Phosphorus and your CKD diet. National Kidney Foundation (2023)View source
Sullivan C, Sayre SS, Leon JB, et al.. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA (2009)
Moe SM, Zidehsarai MP, Chambers MA, et al.. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clinical Journal of the American Society of Nephrology (2011)
Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clinical Journal of the American Society of Nephrology (2008)
Wolf M, Rubin J, Achebe M, et al.. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials. JAMA (2020)
Imel EA, Econs MJ. Approach to the hypophosphatemic patient. Journal of Clinical Endocrinology and Metabolism (2012)
Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ (2008)

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your Phos result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my Phos

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.